QUEBEC CITY, QUEBEC--(Marketwire - May 16, 2008) - Medicago Inc. (TSX VENTURE: MDG) (the “Company”), today announced that its abstract has been selected for poster presentation at the Infectious Diseases Society of America (IDSA) Seasonal and Pandemic Influenza 2008 meeting, held in Arlington, Virginia from May 18-20, 2008. Ms. Nathalie Charland, Product Portfolio manager, will present highlights of the Company’s development of Influenza vaccines generated from plant-made Virus-Like Particles (“VLP”) and the potential of its proprietary manufacturing technology to address global pandemic influenza supply challenges.
